A phase II trial of low-dose metronomic oral vinorelbine as salvage treatment in advanced non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Agelaki, S. [1 ]
Kontopodis, E. D. [1 ]
Kentepozidis, N. [1 ]
Giassas, S. [1 ]
Vamvakas, L. [1 ]
Androulakis, N. [1 ]
Kotsakis, K. [1 ]
Sfakiotaki, G. [1 ]
Mavroudis, D. [1 ]
Georgoulias, V [1 ]
机构：
[1] Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion, Greece
来源：
JOURNAL OF THORACIC ONCOLOGY | 2009年 / 4卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S448 / S448
页数：1
相关论文
共 50 条
  • [21] Phase II trial of alternating intravenous and oral vinorelbine in combination with cisplatin in advanced non-small cell lung cancer
    Elisabetta Campagnoli
    Isabella Garassino
    Armando Santoro
    Fabio De Vincenzo
    Paolo Andrea Zucali
    Giovanni Luca Ceresoli
    Fabio Romano Lutman
    Marco Alloisio
    Hector Josè Soto Parra
    Raffaele Cavina
    Investigational New Drugs, 2007, 25 : 559 - 564
  • [22] Phase I/II trial of vinorelbine and divided-dose carboplatin in advanced non-small cell lung cancer
    Masters, GA
    Hahn, EA
    Shevrin, DH
    Kies, MS
    LUNG CANCER, 2003, 39 (02) : 221 - 226
  • [23] Phase II trial of alternating intravenous and oral vinorelbine in combination with cisplatin in advanced non-small cell lung cancer
    Campagnoli, Elisabetta
    Garassino, Isabella
    Santoro, Armando
    De Vincenzo, Fabio
    Zucali, Paolo Andrea
    Ceresoli, Giovanni Luca
    Lutman, Fabio Romano
    Alloisio, Marco
    Parra, Hector Jose Soto
    Cavina, Raffaele
    INVESTIGATIONAL NEW DRUGS, 2007, 25 (06) : 559 - 564
  • [24] Phase II trials of vinorelbine and docetaxel in the treatment of advanced non-small cell lung cancer
    Krug, LM
    Miller, VA
    SEMINARS IN ONCOLOGY, 1999, 26 (05) : 24 - 26
  • [25] Phase II study of vinorelbine (VNR) and gemcitabine (GEM) in advanced non-small cell lung cancer (NSCLC)
    Firvida, JL
    Rodriguez, R
    Sabin, P
    Castellanos, J
    Mata, JG
    Salgado, M
    Vazquez, S
    Lazaro, M
    Delgado, FM
    ANNALS OF ONCOLOGY, 1998, 9 : 97 - 97
  • [26] DAILY ADMINISTRATION OF ORAL VINORELBINE: DATA FROM A PHASE I TRIAL IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Tufman, Amanda
    Borgmeier, Astrid
    Guetz, Sylvia
    Von Pawel, Joachim
    Rittmeyer, Achim
    Huber, Rudolf M.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S289 - S290
  • [27] A phase II trial of carboplatin/vinorelbine with pegfilgrastim support for the treatment of patients with advanced non-small cell lung cancer
    Riedel, Richard F.
    Andrews, Carolyn
    Garst, Jennifer
    Dunphy, Frank
    Herndon, James E.
    Blackwell, Susan
    Barbour, Sally
    Crawford, Jeffrey
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (06) : 520 - 525
  • [28] PHASE-II TRIAL OF COMBINED RADIOTHERAPY AND DAILY LOW-DOSE CISPLATIN FOR INOPERABLE, LOCALLY ADVANCED NON-SMALL CELL LUNG-CANCER (NSCLC)
    VANHARSKAMP, G
    BOVEN, E
    VERMORKEN, JB
    VANDEUTEKOM, H
    STAM, J
    NJO, KH
    KARIM, ABMF
    TIERIE, AH
    GOLDING, RP
    PINEDO, HM
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1987, 13 (11): : 1735 - 1738
  • [29] Mathematical modeling for Phase I cancer trials: A study of metronomic vinorelbine for advanced non-small cell lung cancer (NSCLC) and mesothelioma patients
    Barlesi, Fabrice
    Imbs, Diane-Charlotte
    Tomasini, Pascale
    Greillier, Laurent
    Galloux, Melissa
    Testot-Ferry, Albane
    Garcia, Melanie
    Elharrar, Xavier
    Pelletier, Annick
    Andre, Nicolas
    Mascaux, Celine
    Lacarelle, Bruno
    El Cheikh, Raouf
    Serre, Raphael
    Ciccolini, Joseph
    Barbolosi, Dominique
    ONCOTARGET, 2017, 8 (29) : 47161 - 47166
  • [30] Concurrent chemoradiation with cisplatin and vinorelbine followed by consolidation with oral vinorelbine in locally advanced non-small cell lung cancer (NSCLC): the phase II CONCAVE study
    Hughes, Brett G. M.
    Ahern, Elizabeth
    Lehman, Margot
    Pratt, Gary
    Dauth, Margaret
    Pritchard, Wendy
    Wockner, Leesa
    Horwood, Keith
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 (03) : 137 - 144
12345